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Abstract Increased, decreased or normal excitability to
transcranial magnetic stimulation (TMS) has been reported
in the motor (M1) and visual cortices of patients with
migraine. Light deprivation (LD) has been reported to
modulate M1 excitability in control subjects (CS). Still,
effects of LD on M1 excitability compared to exposure to
environmental light exposure (EL) had not been previously
described in patients with migraine (MP). To further our
knowledge about differences between CS and MP,
regarding M1 excitability and effects of LD on M1 excit-
ability, we opted for a novel approach by extending mea-
surement conditions. We measured motor thresholds (MTs)
to TMS, short-interval intracortical inhibition, and ratios
between motor-evoked potential amplitudes and supra-
maximal M responses in MP and CS on two different days,
before and after LD or EL. Motor thresholds signiﬁcantly
increased in MP in LD and EL sessions, and remained
stable in CS. There were no signiﬁcant between-group
differences in other measures of TMS. Short-term variation
of MTs was greater in MP compared to CS. Fluctuation in
excitability over hours or days in MP is an issue that, until
now, has been relatively neglected. The results presented
here will help to reconcile conﬂicting observations.
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Introduction
Abnormal cortical excitability is an intriguing piece in the
puzzle of migraine pathogenesis. While strong data support
increase in activity or excitability in the cerebral cortex
measured in visual and motor areas of patients with
migraine (MP), there is also evidence that decreased
excitability leading to decreased preactivation and lack of
habituation to afferent stimuli is migraine’s biological
signature [1–4]. Inconsistencies between these mixed
results have not yet been resolved.
A widely used, powerful, and non-invasive tool to
evaluate cortical excitability in humans is transcranial
magnetic stimulation (TMS) (for a review, see [5]). In MP,
visual and corticospinal or cortico-cortical excitabilities to
TMS have been found to be increased, decreased, or nor-
mal, compared to control subjects without migraine (CS)
[1–4, 6, 7]. The debate was therefore not settled by these
studies probably because, in all of them, only single mea-
sures of excitability were performed in MP and CS.
Interestingly, variability of visual cortical excitability
measured once a day on different days is greater in MP
than in CS [7, 8]. This ﬁnding raises the important point
that increased ﬂuctuation, rather than mere increase or
decrease in excitability, may be a marker of abnormal
neuronal function in migraine. However, whether this
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whether it occurs within a day or over several days, is
unknown.
In contrast to the conﬂicting evidence regarding cortical
excitability to TMS, a well-recognized feature in MP is the
abnormal responsiveness to external stimuli such as envi-
ronmental light [9]. It is known that light deprivation (LD)
modulates visual [10, 11] and motor cortex (M1) [12]
excitability to TMS. Effects of LD on M1 excitability in
MP have not been described.
This is the ﬁrst study to compare variability of motor
cortex excitability within a day and across several days in
MP and CS, before and after LD or exposure to environ-
mental light exposure (EL). We hypothesized that: (1)
variability of excitability would be greater in MP compared
to CS; (2) LD would increase excitability to a greater
extent in MP than in CS.
Methods
Subjects
T w e n t y - s i xw o m e np a r t i c i p a t e di nt h es t u d y :1 7M P
(mean age ± standard error (SE), 35.2 ± 2.8 years), 9 CS
(34.1 ± 4.1 years). Inclusion criteria for MP were: diag-
nosis of migraine (with aura, without aura, or chronic)
according to the International Headache Society criteria
[13], and at least one migraine attack in the month before
the experiments.
Exclusion criteria for all subjects were: left-handedness
according to the Oldﬁeld inventory [14]; abnormal brain
magnetic resonance imaging; contraindications to TMS
[15]; psychiatric conditions other than anxiety or depres-
sion; neurological conditions; in the last 4 weeks, use of
prophylactic migraine drugs (beta-blockers, calcium channel
blockers, antidepressants, or antiepileptic drugs), or any drugs
known to interfere in excitability to TMS [16].
Potential CS were excluded if they had a history of any
headache during lifetime that fulﬁlled criteria for a migraine
attackaccordingtoICHcriteria,anyprimaryheadacheother
than episodic tension-type headache, or any headache in the
month before the experiments. Migraine is more common in
women than in men, so it was not surprising that all MP
volunteers were women [17].Toavoid differencesingender
composition between the groups, male gender was an
exclusion criteria in the CS group. The experimental proto-
col was approved by the ethics committee and conformed to
ethical standards described in the Declaration of Helsinki.
All subjects provided written informed consent.
In MP, migraine history averaged (±SE) 21.1 ± 2.5
years and the mean number (±SE) of days with pain
per month was 13.8 ± 1.6. Median MIDAS (Migraine
Disability Assessment Score) [18] was IV (range I–IV) and
medianusualpainintensity(analogscore0–10)was8(range
6–10).TenMPhadepisodicandseven hadchronicmigraine
(Table 1). Patient 15 fulﬁlled IHS criteria for chronic
migraine but had fewer than 15 days of pain in the month
prior to TMS experiments (partial remission).
Experimental design
Every subject participated in two TMS sessions in a
crossover experimental design (Fig. 1). In all experiments,
subjects were set at rest, comfortably seated. Transcranial
magnetic stimulation was performed before and after
30 min of either LD or EL. This LD or EL extent was
chosen because it was reported that 30 min of LD caused
an increase in motor cortex excitability in CS [12].
During LD, after the initial TMS measurements under
standard room lighting conditions (530 lux), ambient lumi-
nance was reduced to a level just sufﬁcient for the investi-
gator to perform TMS; subjects wore opaque goggles and
reportedcompleteabsenceofperceivedlight.InELsessions,
subjects were only exposed to standard room lighting con-
ditions (530 lux). Therefore, LD was the speciﬁc interven-
tion and EL, the control condition. In both sessions, subjects
listenedtostandardsongsduringthe30 minofLDorELand
were instructed to remain awake during TMS measurements
with their eyes open [12, 19]. These instructions were
important to avoid sleepiness as the subjects remained with
eyes closed, in a relatively resting condition for the 30-min
period of LD or EL experiments.
Theorderofthesessionswasrandomizedacrosssubjects.
The maximum interval between experiments was 1 month
and all experiments were performed between 1 p.m. and
6 p.m.TherewerenosigniﬁcantdifferencesbetweentheCS
andMPgroupsregardingtheintervalsbetweenthetwoTMS
sessions (p = 0.87): 6.8 ± 1.7 days in MP and 6.3 ± 2.2
days in CS. In the MP group, there were no signiﬁcant dif-
ferences (p = 0.73) in the number of days between the last
migraine attack and the LD (2.9 ± 0 days) or EL
(3.0 ± 1.1 days) sessions. One patient did not recall the
exactdateofherlastmigraineepisodebeforeLDandanother
one before EL. Patient 16 reported mild, dull headache,
different from migraine, during EL. The pain subsided
spontaneously. Patients 7 and 13 reported headache in both
experimentalsessions,patient9intheELsessionandpatient
12 in the LD session. None of the patients reported auras
during or up to 24 h before the experiments.
TMS
Transcranial magnetic stimulation biphasic pulses were
delivered to the ‘‘hot spot’’ of the left M1 for the right
abductor pollicis brevis (APB) through a MC-B70
30 J Headache Pain (2012) 13:29–37
123ﬁgure-of-eight coil (2 9 100 mm, 31kT/s) connected to a
MagPro X100 magnetic stimulator (Alpine Biomedical).
The coil was placed tangentially to the scalp, with the
intersection of both wings at a 45 angle with the midline.
Electromyographic (EMG) activity was recorded from
surface electrodes placed over the APB muscle, the
responses ampliﬁed (1,000), ﬁltered (2 Hz–2 kHz), and
recorded on a computerized data acquisition system built
with the LabVIEW graphical programming language
(sampling rate 5 kHz). Its conditional triggering feature
was used to deliver TMS stimuli only when the APB
muscle was relaxed (EMG activity at baseline \50 lV
peak-to-peak amplitude for at least 1 s) [20].
After identiﬁcation of the APB hot spot, the following
TMS measurements [5] were obtained at baseline and
immediately after LD and EL sessions: (a) Resting motor
threshold (MT), a measure of corticomotor excitability
deﬁned as the minimum TMS intensity (measured to the
nearest 1% of the maximum output of the magnetic stim-
ulator and delivered randomly 5–7 s apart) required to
elicit at least three out of six motor-evoked potentials
(MEP) C50 lV in consecutive trials, as previously repor-
ted [21, 22]. Transcranial magnetic stimulation stimulus
intensities were expressed relative to the MT measured
Table 1 Measures of excitability to transcranial magnetic stimulation in patients with migraine
MP Type of
migraine
MT
Pre-EL
MT
Post-EL
MT
Pre-LD
MT
Post-LD
SICI
Pre-EL
SICI
Post-EL
SICI
Pre-LD
SICI
Post-LD
N Pre-EL N Post-EL N Pre-LD N Post-LD
1 Episodic
a 45 50 44 46 49.3 29.9 42.6 74.3 18 21 16 14
2 Episodic
a 36 38 35 34 110.9 61.1 36.1 49.4 21 21 19 19
3 Episodic
a 28 27 35 34 57.5 53.5 29.6 33.9 25 25 17 19
4 Episodic
b 35 41 31 32 11.4 27.2 47.2 21.6 52 31 21 16
5 Episodic
b 39 40 42 44 21.6 43.1 59.9 66.1 19 15 64 19
6 Episodic
b 36 36 35 36 117.8 209.2 105.0 88.2 15 24 25 21
7 Episodic
b 45 50 44 46 147.3 135.3 182.5 141.6 18 25 15 30
8 Episodic
b 37 38 40 40 24.0 70.1 20.9 35.7 25 20 17 18
9 Episodic
b 63 61 58 58 69.7 65.5 91.7 104.9 23 17 21 23
10 Episodic
b 39 41 39 46 9.2 8.3 38.1 8.1 18 25 27 15
11 Chronic 28 31 29 31 72.7 76.09 37.3 21.1 24 15 23 17
12 Chronic 50 50 49 49 28.9 17.7 33.4 33.6 14 13 17 24
13 Chronic 75 75 68 72 31.9 107.4 51.6 51.1 40 22 21 18
14 Chronic 30 33 32 33 57.6 112.2 31.9 129.4 25 25 18 20
15 Chronic 50 55 42 55 10.5 9.5 10.5 2.9 18 20 25 25
16 Chronic 34 37 36 35 99.9 134.3 82.0 86.5 23 14 16 19
17 Chronic 34 33 35 35 11.3 37.3 33.2 92.9 25 20 22 21
Mean 41.4 43.3 40.8 42.7 54.8 70.5 54.9 61.3 23.7 20.8 22.6 19.9
S.E. 2.9 2.8 2.3 2.5 9.8 12.4 9.4 9.5 2.1 1.1 2.6 0.9
Motor thresholds (MT, % of stimulator’s output), short-interval intracortical inhibition (SICI, %), and number of stimuli (N) in determination of MT in
patients with migraine pre- and post-standard room light exposure (EL) and pre- and post-light deprivation (LD)
a With aura
b Without aura
SE standard error
Fig. 1 Experimental paradigm. Visual Analog Mood Scores (VAMS)
and measures of excitability were performed before (left) and after
(right) environmental light exposure (EL, top) and light deprivation
(LD, bottom) sessions in patients with migraine (MP) and in control
subjects (CS). In the EL session, subjects were exposed to ambient
light. In the LD session, goggles were kept in place for 30 min and
until measurements of excitability were ﬁnished. After ﬁnding the hot
spot to register motor-evoked potentials (MEP) in the right abductor
pollicis brevis muscle, motor threshold (MT), short-interval intracor-
tical inhibition (SICI), MEP amplitudes at intensities of 0.9, 1.1, and
1.3 MT, and amplitudes of supraxamaximal M responses (M) were
evaluated before and after EL or LD. In both sessions, subjects were
instructed to remain at rest with eyes open
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123from the APB. Numbers of stimuli to determine MT were
recorded for each subject in each condition. (b) Short-
interval intracortical inhibition (SICI) was measured with
paired-pulse TMS. SICI likely reﬂects intracortical function
in GABAergic inhibitory interneurons [5]. Conditioning
stimulus intensity was set to 80% of the APB MT. The
intensityoftheteststimuluswasthatrequiredtoevokeMEPs
of approximately 0.5–1 mV (MEPTS). This procedure was
described by Kujirai in the classical paired-pulse paradigm
[23]. The order of presentation of inhibitory (2 ms) and
control trial (test stimulus alone) intervals was randomized
across subjects. Twelve paired and 12 control trials were
recorded. Results were expressed as average percentages of
MEP amplitudes in conditioning trials and in test trials
(MEPconditioning stimuli ? test stimuli/MEP test stimuli,%).
(c) MEP peak-to-peak amplitudes at intensities of 0.9, 1.1,
and 1.3 MT. The order of stimulus intensities was random-
ized across subjects. Results are expressed relative to the
maximal peripheral M response peak-to-peak amplitudes
(MEP/M, %). M responses were obtained by supramaximal
stimulationofthemediannerveatthewrist.MEPamplitudes
were expressed relative to the amplitude of the maximal
peripheralMresponse.Thismeasurementallowscontrolling
for differences in muscle bulk and electrode position across
subjects and reﬂects the extent of activation of the spinal
motor neuron pool of a target muscle, by a single TMS pulse
at a given stimulus intensity. Ten trials were performed for
each stimulation intensity. One CS refused M response
recording and the results from one MP were excluded due to
technical problems (MEPs were not saved).
All experiments were performed at the same phase of
the menstrual cycle, or in active dosage and withdrawal
phases in each subject taking low dosage oral contracep-
tives, because previous studies showed that, even though
MT are unchanged by hormonal levels in both MP and CS,
there are differences in SICI measured in the follicular
phase compared to the luteal phase in CS [24, 25].
Subjective states
To evaluate modulation of subjective states by the experi-
mentalinterventions,VisualAnalogMoodScale(VAMS)of
Norris translated into Portuguese [26] was evaluated before
and after the LD and EL experimental sessions. VAMS
consists of 16 analog scale items printed in a single page.
Eachitemiscomposed ofapairofopposite adjective words,
with a horizontal 100-mm line in between the words. For
eachitem,subjectswererequestedtomarkapointontheline
with the distance to each word proportional to his/her feel-
ings at that moment. Cluster analysis grouped the items into
four factors: (1) cognitive impairment, composed of the
items quick-witted/mentally slow, proﬁcient/incompetent,
energetic/lethargic, clear-headed/muzzy, gregarious/with-
drawn, well-coordinated/clumsy, and strong/feeble; (2)
anxiety, made of the items calm/excited, relaxed/tense, and
tranquil/troubled; (3) sedation, composed of alert/drowsy
and attentive/dreamy; (4) discomfort, made of interested/
bored, happy/sad, contented/discontented, and amicable/
antagonistic.
Statistical analysis
Data are presented as mean ± SE if normally distributed
and as median (range) otherwise. Ages of CS and MP were
compared with unpaired t tests. Intervals before the last
migraine episode in LD and EL sessions were compared
using Wilcoxon tests.
Motor threshold, short-interval intracortical inhibition,
number of stimuli for MT determination, and VAMS
scores were analyzed with repeated-measures analysis of
variance (ANOVARM) using the factors GROUP (CS and
MP), TIME (pre and post), CONDITION (LD and EL), and
ORDER OF SESSION (ﬁrst session, LD; or ﬁrst session,
EL). The factor ‘‘ORDER’’ was included in the model to
evaluate carryover bias in the crossover design used in this
study.
MEP/M ratios were analyzed with repeated-measures
analysis of variance with factors GROUP, TIME, CON-
DITION, STIMULUS INTENSITY (0.9, 1.1, and 1.3rMT),
and ORDER OF SESSION.
Tukey’s post hoc tests with adjusted p values were
performed when appropriate. p values \0.05 were con-
sidered to be statistically signiﬁcant. SAS 9.1 and SPSS
17.0 were used for statistical analysis.
Results
Measures of cortical excitability
Motor thresholds
Motor threshold results and the number of stimuli given to
each subject are shown in Tables 1 and 2. ANOVARM
revealed signiﬁcant interactions GROUP 9 TIME [F(1,24) =
6.28; p = 0.02] and GROUP 9 ORDER [F(1,24) = 5.43;
p = 0.03]. There were no signiﬁcant effects ofCONDITION
or interactions between other factors (p[0.05).
Post hoc analysis showed that although MTs did not
change signiﬁcantly in CS (t = 0.46; p = 0.97), they
increased signiﬁcantly in MP after either LD or EL when
compared with results obtained before these interventions
(t =- 3.72; p = 0.0061) (Fig. 2). There were no signiﬁ-
cant effects of ORDER revealed by post hoc Tukey’s tests
(p = 0.085 for CS and p = 0.964 for MP).
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determination was comparable in the LD and EL sessions. No
signiﬁcant effects of GROUP, TIME, CONDITION, ORDER,
or interactions between these factors (p[0.05) were found.
TheseresultsdemonstratethatMTswerelessstableinMP
than in CS over a short period of time, and that LD or EL
conditions did not affect this measurement in both groups,
regardless of whether LD or EL was the ﬁrst experimental
session to be performed.
Short-interval intracortical inhibition
Short-interval intracortical inhibition results are shown in
Tables 1and2.ANOVARMrevealedsigniﬁcantinteractions
GROUP 9 CONDITION 9 ORDER [F(1,24) = 5.41; p =
0.03)] and GROUP 9 TIME [(F(1,24) = 6.23; p = 0.021)],
while post hoc analysis did not show any signiﬁcant effects
(p[0.05 for all comparisons).
MEP/M ratios
There were no signiﬁcant effects of GROUP, TIME, or
ORDER in MEP/M ratios, or interactions between any of
these factors (p[0.05). However, a signiﬁcant effect was
found for STIMULUS INTENSITY [F(2,44) = 134.6;
p B 0.001]. As expected, MEP/M ratios increased at
greater stimulus intensities in both groups (p\0.001 for
all comparisons). In addition, there was a signiﬁcant effect
of CONDITION [F(1,23) = 5.75; p = 0.026]. Overall,
MEP/M ratios were signiﬁcantly higher in the EL session
compared to the LD session (t = 2.08; p = 0.049).
These results are shown in Supplementary Table 1.
Subjective states
Supplementary Tables 2 and 3 show VAMS results.
ANOVARM revealed signiﬁcant effects of TIME
[F(1,24) = 4.48; p = 0.046] and CONDITION [F(1,24) =
4.46; p = 0.046] regarding VAMS scores for cognitive
impairment. In both groups, scores increased after either
LD or EL sessions and were lower in EL compared to LD
sessions.
ANOVARM revealed a signiﬁcant interaction CONDI-
TION 9 TIME [F(1,24) = 6.3; p = 0.019] regarding anxi-
ety scores. There were no signiﬁcant effects of GROUP,
ORDER, or other interactions between any of the factors
analyzed (p[0.05). Differences in anxiety scores were not
Table 2 Measures of excitability to transcranial magnetic stimulation in control subjects
CS MT
Pre-EL
MT
Post-EL
MT
Pre-LD
MT
Post-LD
SICI
Pre-EL
SICI
Post-EL
SICI
Pre-LD
SICI
Post-LD
N
Pre-EL
N
Pre-EL
N
Pre-LD
N
Post-LD
1 33 32 29 31 40.1 23.8 55.1 44.5 44 26 19 17
2 36 34 33 36 54.9 28.0 51.1 36.2 17 41 24 16
3 56 51 58 58 23.8 7.5 15.0 5.3 22 19 13 13
4 57 58 56 56 67.1 38.0 14.9 36.5 20 43 50 18
5 39 40 41 43 145.9 113.9 86.5 86.6 24 18 14 20
6 34 34 31 35 38.3 28.3 63.9 52.7 21 21 21 51
7 45 42 51 43 106.8 46.55 194.2 120.8 29 14 16 17
8 30 30 30 28 69.5 65.8 47.2 40.5 20 17 20 25
9 31 31 31 31 33.8 32.9 41.0 46.1 32 31 17 17
Mean 40.1 39.1 40.0 40.1 64.5 42.8 63.2 52.1 25.4 25.6 21.6 21.6
SE 3.2 3.1 3.7 3.4 12.4 9.8 17.0 10.4 2.6 3.3 3.5 3.6
Motor thresholds (MT, % of stimulator’s output), short-interval intracortical inhibition (SICI, %), and number of stimuli (N) in determination of
MT in control subjects pre- and post-standard room light exposure (EL) and pre- and post-light deprivation (LD)
SE standard error
Fig. 2 Changes in motor thresholds. Absolute differences between
motorthresholds(inpercentageofstimulator’soutput)achievedforthe
light exposure (EL) session (Post-EL–Pre-EL, white columns) and for
light deprivation (LD) session (Post-LD–Pre-LD, black columns)i n
patients with migraine (MP) and control subjects (CS). *p\0.05. NS
nonsigniﬁcant
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123signiﬁcant according to post hoc analysis: pre-EL 9 post-
EL, p = 0.196; pre-LD 9 post-LD, p = 0.136; pre-LD 9
pre-EL, p = 0.354; post-LD 9 post-EL, p = 0.078.
There were no signiﬁcant effects or interactions
regarding VAMS scores for sedation or discomfort
(p[0.05).
In summary, cognitive impairment was greater at the
end of the experimental sessions in both groups, although it
was more prominent in the LD than in the EL sessions.
There were no measurable changes in anxiety, sedation, or
discomfort between groups, across time or conditions.
Discussion
The main result of this study was that MT increased sig-
niﬁcantly within a short period of time (less than 2 h) in
MP, but remained stable in CS. This change cannot be
attributed to differences in muscle relaxation, because the
computer-controlled system used to trigger the magnetic
stimulator insured that TMS pulses were administered only
at rest, during all MT measurements. Furthermore, there
were no signiﬁcant between-group differences regarding
cognitive impairment, anxiety, sedation, or discomfort. The
lack of signiﬁcant differences in MT in the CS group
reported here is in agreement with previous reports
involving measurements repeated seven times within 10 h
[27] and once daily on three different days [27–29], indi-
cating the stability of MT in CS.
Repetitive testing was crucial to observe this MT vari-
abilityandmayexplaindiscrepantresultsinpreviousreports
[1–4]. It is reasonable to think that if MT is less stable in MP
thaninCS,differencesbetweengroupsmayormaynotarise
depending on when the punctual measurements are col-
lected. Our results indicate that controversies about excit-
ability to TMS in MP may partially be due to this factor.
Baseline MTs, measured before LD and EL on different
days did not signiﬁcantly differ in MP in our study, in
contrast to phosphene thresholds that were shown to vary
signiﬁcantly more in MP than CS across days [7, 8]. One
plausible explanation is that ﬂuctuation in visual cortex
excitability does not necessarily parallel ﬂuctuation in M1
excitability. Phosphene thresholds measured once a day
were shown to increase, 1–2 days before migraine attacks
in children, while MT measured once a day did not signi-
ﬁcantly change in the interictal period [6]. Resting MT and
phosphene thresholds were found not to correlate signiﬁ-
cantly in healthy subjects in a number of studies [30–33]
even though a signiﬁcant correlation was found between
active MT (measured during voluntary muscle contraction)
and phosphene thresholds when similar thresholding proce-
dures were employed for both measurements of excitability
[34].
Also, phosphene threshold is known to be more variable
than MT across and within subjects [7, 8, 33] and depends
on subjective responses, while MT relies on objective
determination of MEPs. Finally, the use of different types
of stimulators and coils limit result comparability between
our results and those of studies that evaluated phosphene
thresholds in MP and CS.
The magnitude of change in MT in the MP group was
small(meanaround2%)butsigniﬁcant.MTisafairlystable
TMS measure that can change signiﬁcantly after brain
lesions, such as stroke or amyotrophic lateral sclerosis [35,
36], or administration of drugs that interfere on ionic chan-
nels or on NMDA receptors [16]. On average, MT increases
in 2–10% after administration of antagonists of sodium and
calcium channels [16, 37–41] and decreases in 2.7–6.7%
after administrationof the NMDA antagonistketamine [42].
Therefore, the magnitude of change in MT even after
administrationofthesedrugsisrelativelysmall.Considering
that no overt structural lesions and only subtle changes in
brain excitability would be expected in migraine, we obvi-
ously did not anticipate large shifts in MT in MP.
The signiﬁcant increase in MT observed over a short
period of time in MP may reﬂect abnormal function of
ionic channels [1, 3], because MT can be signiﬁcantly
increased by antagonists of sodium and calcium channels
[16] and for this reason is considered a marker of ion
channel excitability in the motor cortex. Furthermore,
mutations of neuronal ionic channels have been identiﬁed
in rare, familial forms of migraine [43–45]. Neurons with
these mutations can be hypoexcitable and hyperexcitable at
different points in time, i.e., their excitability is more
variable than in non-mutated neurons [46]. Hence,
increased variability in neuronal excitability due to
abnormal function of ionic channels is a candidate expla-
nation to our ﬁndings of greater drifts in MT in MP,
compared to CS.
Motor thresholds depend not only on the activity of ion
channels of motor cortical neurons [16, 27], but is also
inﬂuenced by other factors: corticospinal ﬁber orientation,
distance between the coil and the motor cortex, technique
of measurement (coil positioning, type of coil or magnetic
stimulator), excitability of spinal motor neurons, and pos-
sibly by attention, hormonal ﬂuctuations, and fatigue. None
of these other factors explain our ﬁndings.
First, within-subject comparisons were performed in MT
measurements and, therefore, corticospinal ﬁber orientation
was constant. Second, stimulation technique, including the
number of stimuli for MT determination, was comparable in
all TMS sessions. Although we did not use neuronavigation,
it is unlikely that such an approach would have provided a
different explanation because a previous report demon-
strated no signiﬁcant differences in MT measured with or
without neuronavigation [47]. Third, all experiments were
34 J Headache Pain (2012) 13:29–37
123performed in the afternoon and in the same phase of the
menstrualcycleineachparticipant,andsubjectivestateswere
comparable between the two MP and CS groups. Fourth, no
between-group differences were found in M responses (data
not shown), arguing against spinal mechanisms.
In contrast with MT results, there were no signiﬁcant
differences between groups with regard to SICI or MEP/M
ratios. MEP/M ratios were signiﬁcantly lower under a
condition of less cognitive demand (rest in the dark in the
LD session), consistent with previous reports [19, 48]. A
limitation to interpretation of these ﬁndings is the extreme
heterogeneity in SICI and MEP/M ratios within and across
subjects. This was not unexpected given the reports about
variability of these measures in CS [10, 19, 49].
Motor thresholds were reported to remain unchanged
while MEP amplitudes were reported to increase and SICI
to decrease after 30 min of LD compared to baseline EL
measured in a different experimental session in CS [12]. In
contrast, LD had no signiﬁcant effects on SICI or on MEP/
M ratios in CS or in MP in our study. The reason behind
this discrepancy between studies is likely the difference in
experimental designs: measurements were performed once
in each session in the study of Leon-Sarmiento et al. [12],
at baseline in the EL session and after 30 min of LD in the
LD session. In our study, CS and MP remained at rest for
30 min during exposure to environmental light in the EL
session, and without exposure to light in the LD session.
Measurements were performed before and after LD and
EL. Rest inﬂuences baseline activity in the brain. The
magnitude of the ‘‘rest’’ condition may have exceeded
effects of LD on MT, therefore obscuring any possible
effects of this intervention compared to EL.
Another question that arises from our research is whether
there is a correlation between the degree of ﬂuctuation in
excitability and clinical features (number, duration, severity
ofattacks,useofprophylacticdrugs,gender,andpainduring
TMS).MoststudiesonsinglemeasurementsofMTexcluded
data from patients having migraine attacks at intervals
ranging from 1 week to 24 h before and/or after experi-
ments. This was based on pseudo-normalization of neuro-
physiological measures performed with various techniques
other than TMS [1–4]. However, there is no demonstration
that results of these tests mirror excitability measured with
TMS. Furthermore, the hypothesis that migraine attacks
inﬂuence MT failed to be conﬁrmed in children [6] and has
not been formally tested in adults. Future studies should
includegreatersamplesizes,providedetailedinformationof
migraine attacks for prolonged periods, and perform more
than one MT measurement, within a day and across days.
One exciting, possible application of TMS in a paroxys-
mal disorder such as migraine is to deﬁne surrogate end
points for responsiveness to speciﬁc therapeutic interven-
tions.Inpatientswithepilepsy,seizurecontrolafter1 yearof
treatment with antiepileptic drugs can be predicted from
early increase in MT and intracortical inhibition measured
withTMSafterseveralweeksoftreatment[50].Itispossible
thatchangeorrateofchangeinMTmaybeusefulmarkersto
predict responsiveness of MP to pharmacological or non-
pharmacological interventions. Moreover, TMS itself has
been suggested to be a potential novel non-pharmacological
intervention to treat MP, due to beneﬁcial effects reported
after single-pulse stimulation of the visual cortex in patients
with migraine with aura [51, 52]. If TMS is to be used to
predict clinical improvements, then MT and ﬂuctuation in
MTarecandidatemeasurements.Morestudiesarenecessary
to deﬁne whether TMS can be an adjuvant tool to stratify
patients for speciﬁc therapeutic strategies.
Although our study encompassed patients with
migraine without aura, with aura, and chronic migraine,
we were able to ﬁnd signiﬁcant differences between M1
excitability in MP, compared to CS. Whether variability
in MT differs in different types of migraine or according
to severity of this condition is a matter to be addressed
in future studies. In addition, whether it predisposes to
migraine attacks or is a consequence of them remains a
difﬁcult question.
The results presented here show for the ﬁrst time that
ﬂuctuation in MT is greater in MP compared to CS.
Fluctuation in excitability over hours or days in MP is an
issue that, until now, has been relatively neglected and is
important to understanding contradictory ﬁndings of pre-
vious studies that performed single measures of excitabil-
ity. Many reasons may underlie the stability of electric
activity in cortical neurons, such as the types, quantity, and
activity of ionic channels and the relative strengths of
inhibitory and excitatory synaptic inputs [53]. Adding
ﬂuctuation in cortical excitability to the complex equation
of brain electrical dynamics in migraine will reconcile
conﬂicting results, which may be useful to enlighten the
pathogenesis underlying this condition.
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